{"url_path":"/sec/engnw/8-k/2026-06-10/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-10","source_url":"https://www.sec.gov/Archives/edgar/data/1980845/0001193125-26-265830-index.html","accession_number":"0001193125-26-265830","cik":"0001980845","ticker":"ENGN","issuer_name":"enGene Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1980845/0001193125-26-265830-index.html","primary_entity_key":"0001980845","primary_entity_name":"enGene Therapeutics Inc."},"word_count":204,"has_tables":true,"body_markdown":"## Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nThe 2026 Annual General Meeting of shareholders (the “Annual Meeting”) of enGene Therapeutics Inc. (the “Company”) was held on June 9, 2026 at 8:30 a.m. EDT. A total of 56,196,302 common shares of the Company, no par value (the “Common Shares”) were present or represented by proxy at the Annual Meeting, representing approximately 83.89% of the Company’s 66,989,466 Common Shares that were outstanding and entitled to vote at the Annual Meeting as of the record date of April 28, 2026.\n\nSet forth below, and pursuant to the requirements set out in subsection 11.3 of National Instrument 51-102, are the final voting results for each of the matters submitted to a vote of the shareholders at the Annual Meeting, which matters are each described in further detail in the Company’s definitive Proxy Statement, as filed with the Securities and Exchange Commission on May 8, 2026:\n\nProposal 1 – Election of Directors\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nDirector Nominee\n\nFor\n\nWithhold\n\nBroker Non-Votes\n\nPhilip Astley-Sparke\n\n47,112,414\n\n \n\n306,821\n\n \n\n8,777,067\n\nRonald H.W. Cooper\n\n47,329,848\n\n \n\n89,387\n\n \n\n8,777,067\n\nDr. William Grossman\n\n \n\n47,408,163\n\n \n\n11,072\n\n \n\n8,777,067\n\nMichael Heffernan\n\n \n\n47,408,163\n\n \n\n11,072\n\n \n\n8,777,067\n\n \n\nProposal 2 – Appointment and Remuneration of Auditor\n\n \n\nFor\n\n \n\nWithhold\n\n \n\nBroker Non-Votes\n\n56,180,287\n\n \n\n16,015\n\n \n\n-"}